Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1633952 | 0.94 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9805477 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9805456 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL6037331 | 0.88 | THRB (0.52) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9847146 | 0.87 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2468776 | 0.84 | TSHR (0.60) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2307199 | 0.82 | TSHR (0.58) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL19399230 | 0.82 | TSHR (0.58) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL25426 | 0.81 | TSHR (0.79) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL182045 | 0.81 | TSHR (0.72) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180277787-A1 | THERMALLY STABLE SILVER NANOWIRE TRANSPARENT ELECTRODE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-09-27 | — | — | US | claimed |
| US-9823520-B2 | Liquid crystal display apparatus and method for manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-21 | — | — | US | claimed |
| US-20150168763-A1 | LIQUID CRYSTAL DISPLAY APPARATUS AND METHOD FOR MANUFACTURING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-18 | — | — | US | claimed |
| US-8614278-B2 | Silicone acrylate hybrid composition and method of making same | DOW CORNING CORPORATION (US) | 2013-12-24 | — | — | US | claimed |
| EP-2599847-A1 | A Silicone Acrylate Hybrid Composition and Method of Making Same | Dow Corning Corporation (US) | 2013-06-05 | — | — | EP | claimed |
| CN-103130966-A | A silicone acrylate hybrid composition and method of making same | DOW CORNING | 2013-06-05 | — | — | CN | claimed |
| EP-2024406-B1 | A SILICONE ACRYLATE HYBRID COMPOSITION | DOW CORNING (US) | 2012-08-01 | — | — | EP | claimed |
| US-20120114737-A1 | SILICONE ACRYLATE HYBRID COMPOSITION AND METHOD OF MAKING SAME | DOW SILICONES CORPORATION | 2012-05-10 | — | — | US | claimed |
| CN-101501088-B | Silicone acrylate hybrid compositions | DOW CORNING CORP. (US) | 2011-11-30 | — | — | CN | claimed |
| US-20090196911-A1 | Silicone Acrylate Hybride Composition and Method Of Making Same | DOW SILICONES CORPORATION | 2009-08-06 | — | — | US | claimed |
| CN-101501088-A | Silicone acrylate hybrid compositions | DOW CORNING (US) | 2009-08-05 | — | — | CN | claimed |
| EP-2024406-A2 | A SILICONE ACRYLATE HYBRID COMPOSITION | DOW CORNING CORPORATION (US) | 2009-02-18 | — | — | EP | claimed |
| EP-1940368-A2 | TRANSDERMAL DRUG DELIVERY SYSTEM WITH ACRYLATE OR METHACRYLATE FUNCTIONAL PRESSURE SENSITIVE ADHESIVE COMPOSITION | DOW CORNING CORPORATION (US) | 2008-07-09 | — | — | EP | claimed |
| WO-2007145996-A9 | A SILICONE ACRYLATE HYBRID COMPOSITION | DOW CORNING (US) | 2008-02-14 | — | — | WO | claimed |
| WO-2007145996-A2 | A SILICONE ACRYLATE HYBRID COMPOSITION | DOW CORNING CORPORATION (US) | 2007-12-21 | — | — | WO | claimed |
| WO-2007050580-A2 | TRANSDERMAL DRUG DELIVERY SYSTEM WITH ACRYLATE OR METHACRYLATE FUNCTIONAL PRESSURE SENSITIVE ADHESIVE COMPOSITION | DOW CORNING CORPORATION (US) | 2007-05-03 | — | — | WO | claimed |
| EP-0311348-A2 | Novel macromers containing a polyether moiety, process of preparing them and polymers thereof | Nippon Oil Co., Ltd. (JP) | 1989-04-12 | — | — | EP | claimed |
| EP-4395749-B1 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-5051486-A | Comb like polymers containing siloxane groups with polyoxyalkylene groups | NIPPON OIL CO., LTD. (JP) | 1991-09-24 | — | — | US | disclosed |
| EP-0311348-A2 | Novel macromers containing a polyether moiety, process of preparing them and polymers thereof | Nippon Oil Co., Ltd. (JP) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114737-A1 | SILICONE ACRYLATE HYBRID COMPOSITION AND METHOD OF MAKING SAME | MMS19, CAD, ACR | TSHR 4740/4885THRB 4095/4885POLB 3051/4885 |
| US-20090196911-A1 | Silicone Acrylate Hybride Composition and Method Of Making Same | MMS19, CAD, ACR | TSHR 4760/4885THRB 4098/4885POLB 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.